Latest Prostate cancer Stories
WASHINGTON, March 10, 2015 /PRNewswire-USNewswire/ -- Today, the American Association of Clinical Urologists (AACU), the American Urological Association (AUA), and LUGPA - the three largest
SAN DIEGO, March 9, 2015 /PRNewswire/ -- Epic Sciences and The Prostate Cancer Clinical Trials Consortium (PCCTC), the leading consortium for Phase 1/2 and Phase 2 clinical trials in prostate
QUEBEC CITY, March 6, 2015 /PRNewswire/ - DiagnoCure, Inc.
SYDNEY, March 6, 2015 /PRNewswire/ -- Novogen today announces that Professor Gil Mor MD PhD from Yale Medical School will be presenting pre-clinical data on the lead candidate product, Cantrixil,
HOUSTON, TX and VANCOUVER, March 5, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (TSX-V: EPI) announced today that it has appointed Mr.
Study in collaboration with Belgium-based CRO, ImmuneHealth NAMUR, Belgium, March 5, 2015 /PRNewswire/ -- VolitionRx Limited
New Study Underscores Negative Effects of USPSTF Prostate Cancer Screening Recommendation WASHINGTON, March 4, 2015 /PRNewswire-USNewswire/ -- LUGPA - a professional association representing
AARAU, Switzerland, March 3, 2015 /PRNewswire/ -- App for individualized prostate cancer prevention opens up new possibilities The ProstateCheck app promotes
Research from SIR 2015 in Atlanta demonstrates prostate artery embolization effectiveness for benign prostatic hyperplasia, with low rates of side effect ATLANTA, March 3, 2015 /PRNewswire-USNewswire/
VANCOUVER, Canada and HOUSTON, TX, March 2, 2015 /PRNewswire/ - ESSA Pharma Inc.
More Images (2 images) »